Physician profile
Jay Michael Dutton
NPI 1700886116
$3,696.29
in general payments reported to CMS, 2019-2025
18 companies · $427 in 2025
The $427 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,410 · 2020: $474 · 2021: $698 · 2022: $337 · 2023: $122 · 2024: $228 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $714.92 | 2019-2021 | |
| Stryker Corporation | $602.93 | 2019-2025 | Na |
| Aerin Medical INC. | $562.11 | 2019-2022 | |
| Medtronic, INC. | $461.25 | 2022-2025 | Propel, Pteye Parathyroid Detection System |
| Medtronic USA, INC. | $321.47 | 2019 | |
| Optinose US, INC. | $203.12 | 2020-2022 | |
| Genzyme Corporation | $188.73 | 2019-2025 | |
| Neurent Medical Limited | $173.46 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Regeneron Healthcare Solutions, INC. | $84.22 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $80.13 | 2021-2025 | Nucala |
| Karl Storz Endoscopy-America | $68.89 | 2020 | |
| Acclarent, INC | $65.64 | 2019 | |
| Galderma Laboratories, L.P. | $47.62 | 2019-2022 | |
| Smith+Nephew, INC. | $41.74 | 2023 | |
| Alk-Abello, INC | $28.70 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $19.88 | 2019 | |
| Kaleo, INC. | $16.74 | 2021 | |
| Integra Lifesciences Corporation | $14.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Dutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.